Ancestral Mutations Acquired in Refrex-1, a Restriction Factor against Feline Retroviruses, during its Cooption and Domestication
Endogenous retroviruses (ERVs) are remnants of ancestral retroviral infections of germ cells. Retroviral endogenization is an adaptation process for the host genome, and ERVs are gradually attenuated or inactivated by mutation. However, some ERVs that have been “domesticated” by their hosts eventual...
Saved in:
Published in | Journal of virology Vol. 90; no. 3; pp. 1470 - 1485 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
01.02.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Endogenous retroviruses (ERVs) are remnants of ancestral retroviral infections of germ cells. Retroviral endogenization is an adaptation process for the host genome, and ERVs are gradually attenuated or inactivated by mutation. However, some ERVs that have been “domesticated” by their hosts eventually gain physiological functions, such as placentation or viral resistance. We previously reported the discovery of Refrex-1, a soluble antiretroviral factor in domestic cats that specifically inhibits infection by feline leukemia virus subgroup D (FeLV-D), a chimeric virus of FeLV, and a feline ERV, ERV-DC. Refrex-1 is a truncated envelope protein (Env) encoded by both ERV-DC7 and ERV-DC16 proviral loci. Here, we reconstituted ancestral and functional Env from ERV-DC7 and ERV-DC16 envelope genes (
env
) by inducing reverse mutations. Unexpectedly, ERV-DC7 and ERV-DC16 full-length Env (ERV-DC7 fl and ERV-DC16 fl), reconstructed by removing stop codons, did not produce infectious viral particles. ERV-DC7 fl and ERV-DC16 fl were highly expressed in cells but were not cleaved into surface subunits (SU) and transmembrane subunits, nor were they incorporated into virions. G407R/N427I-A429T and Y431D substitutions within the SU C-terminal domain of ERV-DC7 fl and ERV-DC16 fl, respectively, caused these dysfunctions. The residues glycine 407 and tyrosine 431 are relatively conserved among infectious gammaretroviruses, and their substitution causes the same dysfunctions as the tested retroviruses. Our results reveal that specific mutations within the SU C-terminal domain suppressed Env cleavage and incorporation into virions and indicate that these mutations contributed to the domestication of Refrex-1 through multistep events that occurred in the postintegration period.
IMPORTANCE
Domestic cats are colonized with various exogenous retroviruses (exRVs), such as feline leukemia virus (FeLV), and their genomes contain numerous ERVs, some of which are replication-competent proviruses. The feline hosts, exRVs, and ERVs have complicated genetic interactions and provide an interesting field model for triangular relationships: recombination between FeLV and ERV-DC, which is a feline ERV, generated FeLV-D, a chimeric virus, and FeLV-D is restricted by Refrex-1, an antiretroviral factor corresponding to truncated Env of ERV-DC7 and ERV-DC16. Here, we reconstructed ancestral, functional Env from ERV-DC7 and ERV-DC16
env
by inducing reverse mutations to elucidate how Refrex-1 was generated from its ancestor. Our results reveal that they were repeatedly inactivated by mutations preventing Env maturation. Our results provide insights into how ERVs were “domesticated” by their hosts and identify the mutations that mediated these evolutions. Notably, experiments that restore inactivated ERVs might uncover previously unrecognized features or properties of retroviruses. |
---|---|
AbstractList | Endogenous retroviruses (ERVs) are remnants of ancestral retroviral infections of germ cells. Retroviral endogenization is an adaptation process for the host genome, and ERVs are gradually attenuated or inactivated by mutation. However, some ERVs that have been “domesticated” by their hosts eventually gain physiological functions, such as placentation or viral resistance. We previously reported the discovery of Refrex-1, a soluble antiretroviral factor in domestic cats that specifically inhibits infection by feline leukemia virus subgroup D (FeLV-D), a chimeric virus of FeLV, and a feline ERV, ERV-DC. Refrex-1 is a truncated envelope protein (Env) encoded by both ERV-DC7 and ERV-DC16 proviral loci. Here, we reconstituted ancestral and functional Env from ERV-DC7 and ERV-DC16 envelope genes (
env
) by inducing reverse mutations. Unexpectedly, ERV-DC7 and ERV-DC16 full-length Env (ERV-DC7 fl and ERV-DC16 fl), reconstructed by removing stop codons, did not produce infectious viral particles. ERV-DC7 fl and ERV-DC16 fl were highly expressed in cells but were not cleaved into surface subunits (SU) and transmembrane subunits, nor were they incorporated into virions. G407R/N427I-A429T and Y431D substitutions within the SU C-terminal domain of ERV-DC7 fl and ERV-DC16 fl, respectively, caused these dysfunctions. The residues glycine 407 and tyrosine 431 are relatively conserved among infectious gammaretroviruses, and their substitution causes the same dysfunctions as the tested retroviruses. Our results reveal that specific mutations within the SU C-terminal domain suppressed Env cleavage and incorporation into virions and indicate that these mutations contributed to the domestication of Refrex-1 through multistep events that occurred in the postintegration period.
IMPORTANCE
Domestic cats are colonized with various exogenous retroviruses (exRVs), such as feline leukemia virus (FeLV), and their genomes contain numerous ERVs, some of which are replication-competent proviruses. The feline hosts, exRVs, and ERVs have complicated genetic interactions and provide an interesting field model for triangular relationships: recombination between FeLV and ERV-DC, which is a feline ERV, generated FeLV-D, a chimeric virus, and FeLV-D is restricted by Refrex-1, an antiretroviral factor corresponding to truncated Env of ERV-DC7 and ERV-DC16. Here, we reconstructed ancestral, functional Env from ERV-DC7 and ERV-DC16
env
by inducing reverse mutations to elucidate how Refrex-1 was generated from its ancestor. Our results reveal that they were repeatedly inactivated by mutations preventing Env maturation. Our results provide insights into how ERVs were “domesticated” by their hosts and identify the mutations that mediated these evolutions. Notably, experiments that restore inactivated ERVs might uncover previously unrecognized features or properties of retroviruses. Endogenous retroviruses (ERVs) are remnants of ancestral retroviral infections of germ cells. Retroviral endogenization is an adaptation process for the host genome, and ERVs are gradually attenuated or inactivated by mutation. However, some ERVs that have been "domesticated" by their hosts eventually gain physiological functions, such as placentation or viral resistance. We previously reported the discovery of Refrex-1, a soluble antiretroviral factor in domestic cats that specifically inhibits infection by feline leukemia virus subgroup D (FeLV-D), a chimeric virus of FeLV, and a feline ERV, ERV-DC. Refrex-1 is a truncated envelope protein (Env) encoded by both ERV-DC7 and ERV-DC16 proviral loci. Here, we reconstituted ancestral and functional Env from ERV-DC7 and ERV-DC16 envelope genes (env) by inducing reverse mutations. Unexpectedly, ERV-DC7 and ERV-DC16 full-length Env (ERV-DC7 fl and ERV-DC16 fl), reconstructed by removing stop codons, did not produce infectious viral particles. ERV-DC7 fl and ERV-DC16 fl were highly expressed in cells but were not cleaved into surface subunits (SU) and transmembrane subunits, nor were they incorporated into virions. G407R/N427I-A429T and Y431D substitutions within the SU C-terminal domain of ERV-DC7 fl and ERV-DC16 fl, respectively, caused these dysfunctions. The residues glycine 407 and tyrosine 431 are relatively conserved among infectious gammaretroviruses, and their substitution causes the same dysfunctions as the tested retroviruses. Our results reveal that specific mutations within the SU C-terminal domain suppressed Env cleavage and incorporation into virions and indicate that these mutations contributed to the domestication of Refrex-1 through multistep events that occurred in the postintegration period. IMPORTANCE Domestic cats are colonized with various exogenous retroviruses (exRVs), such as feline leukemia virus (FeLV), and their genomes contain numerous ERVs, some of which are replication-competent proviruses. The feline hosts, exRVs, and ERVs have complicated genetic interactions and provide an interesting field model for triangular relationships: recombination between FeLV and ERV-DC, which is a feline ERV, generated FeLV-D, a chimeric virus, and FeLV-D is restricted by Refrex-1, an antiretroviral factor corresponding to truncated Env of ERV-DC7 and ERV-DC16. Here, we reconstructed ancestral, functional Env from ERV-DC7 and ERV-DC16 env by inducing reverse mutations to elucidate how Refrex-1 was generated from its ancestor. Our results reveal that they were repeatedly inactivated by mutations preventing Env maturation. Our results provide insights into how ERVs were "domesticated" by their hosts and identify the mutations that mediated these evolutions. Notably, experiments that restore inactivated ERVs might uncover previously unrecognized features or properties of retroviruses. Endogenous retroviruses (ERVs) are remnants of ancestral retroviral infections of germ cells. Retroviral endogenization is an adaptation process for the host genome, and ERVs are gradually attenuated or inactivated by mutation. However, some ERVs that have been "domesticated" by their hosts eventually gain physiological functions, such as placentation or viral resistance. We previously reported the discovery of Refrex-1, a soluble antiretroviral factor in domestic cats that specifically inhibits infection by feline leukemia virus subgroup D (FeLV-D), a chimeric virus of FeLV, and a feline ERV, ERV-DC. Refrex-1 is a truncated envelope protein (Env) encoded by both ERV-DC7 and ERV-DC16 proviral loci. Here, we reconstituted ancestral and functional Env from ERV-DC7 and ERV-DC16 envelope genes (env) by inducing reverse mutations. Unexpectedly, ERV-DC7 and ERV-DC16 full-length Env (ERV-DC7 fl and ERV-DC16 fl), reconstructed by removing stop codons, did not produce infectious viral particles. ERV-DC7 fl and ERV-DC16 fl were highly expressed in cells but were not cleaved into surface subunits (SU) and transmembrane subunits, nor were they incorporated into virions. G407R/N427I-A429T and Y431D substitutions within the SU C-terminal domain of ERV-DC7 fl and ERV-DC16 fl, respectively, caused these dysfunctions. The residues glycine 407 and tyrosine 431 are relatively conserved among infectious gammaretroviruses, and their substitution causes the same dysfunctions as the tested retroviruses. Our results reveal that specific mutations within the SU C-terminal domain suppressed Env cleavage and incorporation into virions and indicate that these mutations contributed to the domestication of Refrex-1 through multistep events that occurred in the postintegration period. Domestic cats are colonized with various exogenous retroviruses (exRVs), such as feline leukemia virus (FeLV), and their genomes contain numerous ERVs, some of which are replication-competent proviruses. The feline hosts, exRVs, and ERVs have complicated genetic interactions and provide an interesting field model for triangular relationships: recombination between FeLV and ERV-DC, which is a feline ERV, generated FeLV-D, a chimeric virus, and FeLV-D is restricted by Refrex-1, an antiretroviral factor corresponding to truncated Env of ERV-DC7 and ERV-DC16. Here, we reconstructed ancestral, functional Env from ERV-DC7 and ERV-DC16 env by inducing reverse mutations to elucidate how Refrex-1 was generated from its ancestor. Our results reveal that they were repeatedly inactivated by mutations preventing Env maturation. Our results provide insights into how ERVs were "domesticated" by their hosts and identify the mutations that mediated these evolutions. Notably, experiments that restore inactivated ERVs might uncover previously unrecognized features or properties of retroviruses. Endogenous retroviruses (ERVs) are remnants of ancestral retroviral infections of germ cells. Retroviral endogenization is an adaptation process for the host genome, and ERVs are gradually attenuated or inactivated by mutation. However, some ERVs that have been "domesticated" by their hosts eventually gain physiological functions, such as placentation or viral resistance. We previously reported the discovery of Refrex-1, a soluble antiretroviral factor in domestic cats that specifically inhibits infection by feline leukemia virus subgroup D (FeLV-D), a chimeric virus of FeLV, and a feline ERV, ERV-DC. Refrex-1 is a truncated envelope protein (Env) encoded by both ERV-DC7 and ERV-DC16 proviral loci. Here, we reconstituted ancestral and functional Env from ERV-DC7 and ERV-DC16 envelope genes (env) by inducing reverse mutations. Unexpectedly, ERV-DC7 and ERV-DC16 full-length Env (ERV-DC7 fl and ERV-DC16 fl), reconstructed by removing stop codons, did not produce infectious viral particles. ERV-DC7 fl and ERV-DC16 fl were highly expressed in cells but were not cleaved into surface subunits (SU) and transmembrane subunits, nor were they incorporated into virions. G407R/N427I-A429T and Y431D substitutions within the SU C-terminal domain of ERV-DC7 fl and ERV-DC16 fl, respectively, caused these dysfunctions. The residues glycine 407 and tyrosine 431 are relatively conserved among infectious gammaretroviruses, and their substitution causes the same dysfunctions as the tested retroviruses. Our results reveal that specific mutations within the SU C-terminal domain suppressed Env cleavage and incorporation into virions and indicate that these mutations contributed to the domestication of Refrex-1 through multistep events that occurred in the postintegration period.UNLABELLEDEndogenous retroviruses (ERVs) are remnants of ancestral retroviral infections of germ cells. Retroviral endogenization is an adaptation process for the host genome, and ERVs are gradually attenuated or inactivated by mutation. However, some ERVs that have been "domesticated" by their hosts eventually gain physiological functions, such as placentation or viral resistance. We previously reported the discovery of Refrex-1, a soluble antiretroviral factor in domestic cats that specifically inhibits infection by feline leukemia virus subgroup D (FeLV-D), a chimeric virus of FeLV, and a feline ERV, ERV-DC. Refrex-1 is a truncated envelope protein (Env) encoded by both ERV-DC7 and ERV-DC16 proviral loci. Here, we reconstituted ancestral and functional Env from ERV-DC7 and ERV-DC16 envelope genes (env) by inducing reverse mutations. Unexpectedly, ERV-DC7 and ERV-DC16 full-length Env (ERV-DC7 fl and ERV-DC16 fl), reconstructed by removing stop codons, did not produce infectious viral particles. ERV-DC7 fl and ERV-DC16 fl were highly expressed in cells but were not cleaved into surface subunits (SU) and transmembrane subunits, nor were they incorporated into virions. G407R/N427I-A429T and Y431D substitutions within the SU C-terminal domain of ERV-DC7 fl and ERV-DC16 fl, respectively, caused these dysfunctions. The residues glycine 407 and tyrosine 431 are relatively conserved among infectious gammaretroviruses, and their substitution causes the same dysfunctions as the tested retroviruses. Our results reveal that specific mutations within the SU C-terminal domain suppressed Env cleavage and incorporation into virions and indicate that these mutations contributed to the domestication of Refrex-1 through multistep events that occurred in the postintegration period.Domestic cats are colonized with various exogenous retroviruses (exRVs), such as feline leukemia virus (FeLV), and their genomes contain numerous ERVs, some of which are replication-competent proviruses. The feline hosts, exRVs, and ERVs have complicated genetic interactions and provide an interesting field model for triangular relationships: recombination between FeLV and ERV-DC, which is a feline ERV, generated FeLV-D, a chimeric virus, and FeLV-D is restricted by Refrex-1, an antiretroviral factor corresponding to truncated Env of ERV-DC7 and ERV-DC16. Here, we reconstructed ancestral, functional Env from ERV-DC7 and ERV-DC16 env by inducing reverse mutations to elucidate how Refrex-1 was generated from its ancestor. Our results reveal that they were repeatedly inactivated by mutations preventing Env maturation. Our results provide insights into how ERVs were "domesticated" by their hosts and identify the mutations that mediated these evolutions. Notably, experiments that restore inactivated ERVs might uncover previously unrecognized features or properties of retroviruses.IMPORTANCEDomestic cats are colonized with various exogenous retroviruses (exRVs), such as feline leukemia virus (FeLV), and their genomes contain numerous ERVs, some of which are replication-competent proviruses. The feline hosts, exRVs, and ERVs have complicated genetic interactions and provide an interesting field model for triangular relationships: recombination between FeLV and ERV-DC, which is a feline ERV, generated FeLV-D, a chimeric virus, and FeLV-D is restricted by Refrex-1, an antiretroviral factor corresponding to truncated Env of ERV-DC7 and ERV-DC16. Here, we reconstructed ancestral, functional Env from ERV-DC7 and ERV-DC16 env by inducing reverse mutations to elucidate how Refrex-1 was generated from its ancestor. Our results reveal that they were repeatedly inactivated by mutations preventing Env maturation. Our results provide insights into how ERVs were "domesticated" by their hosts and identify the mutations that mediated these evolutions. Notably, experiments that restore inactivated ERVs might uncover previously unrecognized features or properties of retroviruses. |
Author | Kawasaki, Junna Ito, Jumpei Baba, Takuya Nishigaki, Kazuo |
Author_xml | – sequence: 1 givenname: Jumpei surname: Ito fullname: Ito, Jumpei organization: Laboratory of Molecular Immunology and Infectious Disease, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yoshida, Yamaguchi, Japan – sequence: 2 givenname: Takuya surname: Baba fullname: Baba, Takuya organization: Laboratory of Molecular Immunology and Infectious Disease, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yoshida, Yamaguchi, Japan – sequence: 3 givenname: Junna surname: Kawasaki fullname: Kawasaki, Junna organization: Laboratory of Molecular Immunology and Infectious Disease, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yoshida, Yamaguchi, Japan – sequence: 4 givenname: Kazuo surname: Nishigaki fullname: Nishigaki, Kazuo organization: Laboratory of Molecular Immunology and Infectious Disease, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yoshida, Yamaguchi, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26581999$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkkFvEzEQhS1URNPCjTPykUO2jL3rXfuCFAUCRUVICBA3y7Fng9HGTu3dCo78c5ykVIA4cPJI_ubNPM07IychBiTkMYMLxrh89ubT5QUwBU3FxD0yY6BkJQRrTsgMgPNK1PLzKTnL-SsAa5q2eUBOeSskU0rNyI9FsJjHZAb6dhrN6GPIdGGvJ5_QUR_oe-wTfqvYnJpSF9LbPURXxo4xUbMxPuSRrnDwAQsxpnjj05Qxz6mbkg8b6sdMlzHuDn0mOPoibouSt4dxD8n93gwZH92-5-Tj6uWH5evq6t2ry-XiqrKNrMeqB3Rr0bJetbWQ4EzdoK07bgQ46CQKVNYWyLhauhobXis0XDHerttim9fn5PlRdzett-gshr1rvUt-a9J3HY3Xf_4E_0Vv4o1uOqZagCLw9FYgxeupGNBbny0OgwkYp6xZ10rRAXT_hYICEGyPPvl9rbt9fp2oAPMjYFPMOWF_hzDQ-wTokgB9SIBmouD8L9z6412LKT_8u-knqaO1oQ |
CitedBy_id | crossref_primary_10_1073_pnas_2114441119 crossref_primary_10_1186_s12977_017_0351_8 crossref_primary_10_1038_s41579_019_0189_2 crossref_primary_10_3389_fcimb_2024_1404431 crossref_primary_10_1128_jvi_00229_22 crossref_primary_10_3390_v10010029 crossref_primary_10_1371_journal_pbio_3001826 crossref_primary_10_7554_eLife_22519 crossref_primary_10_3390_v10040179 crossref_primary_10_1016_j_celrep_2023_113065 crossref_primary_10_1128_JVI_01324_19 crossref_primary_10_1093_molbev_msae061 |
Cites_doi | 10.1016/S1672-0229(07)60007-2 10.1128/jvi.58.3.825-834.1986 10.1038/35057062 10.1128/JVI.01267-13 10.1002/9780470649367 10.1128/jvi.69.8.4675-4682.1995 10.1128/JVI.75.22.11244-11248.2001 10.1128/JVI.72.7.5955-5966.1998 10.1016/j.placenta.2012.05.005 10.1371/journal.pone.0061009 10.1016/S0378-1119(97)00384-3 10.1073/pnas.071432398 10.1093/molbev/mst197 10.1186/1742-4690-2-52 10.1128/jvi.61.9.2852-2856.1987 10.1038/382826a0 10.1007/BF01731581 10.1155/2012/682850 10.1128/JVI.00288-14 10.1128/jvi.66.2.865-874.1992 10.1016/j.ympev.2009.02.023 10.1016/0042-6822(83)90324-0 10.1128/JVI.00280-12 10.1093/molbev/msi088 10.1016/S0021-9258(18)53779-0 10.1016/j.virol.2010.06.004 10.1128/JVI.73.7.5621-5629.1999 10.1038/360358a0 10.1038/35001608 10.1016/j.vetimm.2011.06.003 10.1182/blood.V95.3.1093.003k01_1093_1099 10.1126/science.287.5459.1828 10.1128/JVI.75.22.10563-10572.2001 10.1128/JVI.73.8.6500-6505.1999 10.1073/pnas.0307800101 10.1128/JVI.73.1.152-160.1999 10.1016/j.micinf.2007.09.012 10.1093/nar/gkr562 10.1128/jvi.63.10.4234-4241.1989 10.1073/pnas.0704313104 10.1016/0168-1702(88)90035-4 10.1016/j.virol.2010.06.017 10.1128/JVI.80.7.3378-3385.2006 10.1128/JVI.03653-14 10.1038/onc.2013.366 10.1007/s00018-006-6201-9 10.1128/JVI.79.24.15573-15577.2005 10.1093/oxfordjournals.molbev.a004108 10.1128/jvi.63.12.5405-5412.1989 10.1371/journal.ppat.0030010 10.1128/JVI.79.15.9677-9684.2005 10.1128/jvi.66.8.4966-4971.1992 10.1128/jvi.64.3.1033-1043.1990 10.1128/jvi.4.5.549-553.1969 10.1128/JVI.73.6.5034-5042.1999 10.1126/science.155.3761.461 10.1128/JVI.76.16.8218-8224.2002 10.1038/nature01262 10.1128/jvi.71.7.5652-5657.1997 10.3390/v7010001 10.1126/science.277.5332.1662 10.1128/jvi.49.2.629-632.1984 10.1093/nar/gkh340 10.1128/jvi.66.2.1219-1222.1992 10.1128/jvi.45.1.1-9.1983 10.1128/jvi.55.3.768-777.1985 10.1099/0022-1317-36-1-59 10.1128/jvi.71.9.7012-7019.1997 |
ContentType | Journal Article |
Copyright | Copyright © 2016, American Society for Microbiology. All Rights Reserved. Copyright © 2016, American Society for Microbiology. All Rights Reserved. 2016 American Society for Microbiology |
Copyright_xml | – notice: Copyright © 2016, American Society for Microbiology. All Rights Reserved. – notice: Copyright © 2016, American Society for Microbiology. All Rights Reserved. 2016 American Society for Microbiology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7U9 H94 5PM |
DOI | 10.1128/JVI.01904-15 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Virology and AIDS Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Virology and AIDS Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Refrex-1 Ancestral Mutations Acquired in Domestication |
EISSN | 1098-5514 |
EndPage | 1485 |
ExternalDocumentID | PMC4719600 26581999 10_1128_JVI_01904_15 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: JSPS KAKENHI grantid: 15H04602 |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAFWJ AAGFI AAYJJ AAYXX ABPPZ ACGFO ACNCT ADBBV ADXHL AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CITATION CS3 D0S DIK E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A O9- OHT OK1 P2P RHI RNS RPM RSF TR2 UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM CGR CUY CVF ECM EIF NPM RHF UCJ 7X8 7U9 H94 5PM |
ID | FETCH-LOGICAL-c483t-f0edb561f963580da34ec372a50d078e5e9ccf0ead38d3e4239ea29126b614423 |
ISSN | 0022-538X 1098-5514 |
IngestDate | Thu Aug 21 18:15:29 EDT 2025 Fri Jul 11 03:29:35 EDT 2025 Fri Jul 11 11:26:25 EDT 2025 Thu Jan 02 23:11:04 EST 2025 Tue Jul 01 01:02:42 EDT 2025 Thu Apr 24 23:05:20 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | Copyright © 2016, American Society for Microbiology. All Rights Reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c483t-f0edb561f963580da34ec372a50d078e5e9ccf0ead38d3e4239ea29126b614423 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Citation Ito J, Baba T, Kawasaki J, Nishigaki K. 2016. Ancestral mutations acquired in Refrex-1, a restriction factor against feline retroviruses, during its cooption and domestication. J Virol 90:1470–1485. doi:10.1128/JVI.01904-15. |
OpenAccessLink | https://jvi.asm.org/content/jvi/90/3/1470.full.pdf |
PMID | 26581999 |
PQID | 1760900510 |
PQPubID | 23479 |
PageCount | 16 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4719600 proquest_miscellaneous_1768570070 proquest_miscellaneous_1760900510 pubmed_primary_26581999 crossref_primary_10_1128_JVI_01904_15 crossref_citationtrail_10_1128_JVI_01904_15 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-02-01 |
PublicationDateYYYYMMDD | 2016-02-01 |
PublicationDate_xml | – month: 02 year: 2016 text: 2016-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | Journal of virology |
PublicationTitleAlternate | J Virol |
PublicationYear | 2016 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_3_50_2 e_1_3_3_71_2 e_1_3_3_16_2 e_1_3_3_18_2 e_1_3_3_39_2 e_1_3_3_12_2 e_1_3_3_37_2 e_1_3_3_58_2 e_1_3_3_14_2 e_1_3_3_35_2 e_1_3_3_56_2 e_1_3_3_33_2 e_1_3_3_54_2 e_1_3_3_10_2 e_1_3_3_31_2 e_1_3_3_52_2 e_1_3_3_40_2 e_1_3_3_5_2 e_1_3_3_7_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 Rasheed S (e_1_3_3_51_2) 1980 e_1_3_3_23_2 e_1_3_3_48_2 e_1_3_3_69_2 Nei M (e_1_3_3_61_2) 1986; 3 e_1_3_3_25_2 e_1_3_3_46_2 e_1_3_3_67_2 e_1_3_3_44_2 e_1_3_3_65_2 e_1_3_3_3_2 e_1_3_3_21_2 e_1_3_3_42_2 e_1_3_3_63_2 e_1_3_3_70_2 e_1_3_3_17_2 e_1_3_3_19_2 e_1_3_3_38_2 e_1_3_3_13_2 e_1_3_3_36_2 e_1_3_3_59_2 e_1_3_3_15_2 e_1_3_3_34_2 e_1_3_3_32_2 e_1_3_3_55_2 e_1_3_3_11_2 e_1_3_3_30_2 e_1_3_3_53_2 e_1_3_3_72_2 e_1_3_3_62_2 e_1_3_3_60_2 Jones DT (e_1_3_3_57_2) 1992; 8 e_1_3_3_6_2 e_1_3_3_8_2 e_1_3_3_28_2 e_1_3_3_49_2 e_1_3_3_24_2 e_1_3_3_47_2 e_1_3_3_26_2 e_1_3_3_45_2 e_1_3_3_68_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_43_2 e_1_3_3_66_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_41_2 e_1_3_3_64_2 9358069 - Gene. 1997 Oct 15;199(1-2):293-301 23966402 - J Virol. 2013 Nov;87(22):12029-40 16107223 - Retrovirology. 2005;2:52 20591459 - Virology. 2010 Sep 15;405(1):214-24 7609032 - J Virol. 1995 Aug;69(8):4675-82 8381404 - J Biol Chem. 1993 Feb 5;268(4):2329-36 2304138 - J Virol. 1990 Mar;64(3):1033-43 22695103 - Placenta. 2012 Sep;33(9):663-71 10710311 - Science. 2000 Mar 10;287(5459):1828-30 25549291 - Viruses. 2015 Jan;7(1):1-26 10400745 - J Virol. 1999 Aug;73(8):6500-5 9261431 - J Virol. 1997 Sep;71(9):7012-9 15659556 - Mol Biol Evol. 2005 Apr;22(4):814-7 8752279 - Nature. 1996 Aug 29;382(6594):826-9 1309898 - J Virol. 1992 Feb;66(2):1219-22 17257061 - PLoS Pathog. 2007 Jan;3(1):e10 22811910 - Mol Biol Int. 2012;2012:682850 11602766 - J Virol. 2001 Nov;75(22):11244-8 9287219 - Science. 1997 Sep 12;277(5332):1662-6 11919294 - Mol Biol Evol. 2002 Apr;19(4):526-33 10648427 - Blood. 2000 Feb 1;95(3):1093-9 15044706 - Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4894-9 6192586 - Virology. 1983 Jul 15;128(1):127-39 10364311 - J Virol. 1999 Jul;73(7):5621-9 11602698 - J Virol. 2001 Nov;75(22):10563-72 22674983 - J Virol. 2012 Aug;86(16):8634-44 17531802 - Genomics Proteomics Bioinformatics. 2006 Nov;4(4):259-63 24132122 - Mol Biol Evol. 2013 Dec;30(12):2725-9 9188643 - J Virol. 1997 Jul;71(7):5652-7 6296423 - J Virol. 1983 Jan;45(1):1-9 21771862 - Nucleic Acids Res. 2011 Nov 1;39(20):8728-39 1633570 - Comput Appl Biosci. 1992 Jun;8(3):275-82 6319767 - J Virol. 1984 Feb;49(2):629-32 24013223 - Oncogene. 2014 Jul 24;33(30):3947-58 19298858 - Mol Phylogenet Evol. 2009 Jun;51(3):465-71 11274436 - Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4113-8 16014929 - J Virol. 2005 Aug;79(15):9677-84 16306628 - J Virol. 2005 Dec;79(24):15573-7 10233966 - J Virol. 1999 Jun;73(6):5034-42 1360148 - Nature. 1992 Nov 26;360(6402):358-61 17959780 - Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17506-11 10693809 - Nature. 2000 Feb 17;403(6771):785-9 16871371 - Cell Mol Life Sci. 2006 Aug;63(16):1906-11 12466850 - Nature. 2002 Dec 5;420(6915):520-62 886304 - J Gen Virol. 1977 Jul;36(1):59-74 25653437 - J Virol. 2015 Apr;89(8):4047-50 9621058 - J Virol. 1998 Jul;72(7):5955-66 2555565 - J Virol. 1989 Dec;63(12):5405-12 15034147 - Nucleic Acids Res. 2004;32(5):1792-7 21807418 - Vet Immunol Immunopathol. 2011 Oct 15;143(3-4):190-201 18023391 - Microbes Infect. 2007 Nov-Dec;9(14-15):1590-6 3039173 - J Virol. 1987 Sep;61(9):2852-6 16537605 - J Virol. 2006 Apr;80(7):3378-85 1370559 - J Virol. 1992 Feb;66(2):865-74 1629961 - J Virol. 1992 Aug;66(8):4966-71 12134027 - J Virol. 2002 Aug;76(16):8218-24 2778873 - J Virol. 1989 Oct;63(10):4234-41 2833049 - Virus Res. 1988 Feb;9(2-3):263-83 3444411 - Mol Biol Evol. 1986 Sep;3(5):418-26 11237011 - Nature. 2001 Feb 15;409(6822):860-921 20655565 - Virology. 2010 Sep 30;405(2):548-55 4311790 - J Virol. 1969 Nov;4(5):549-53 24696495 - J Virol. 2014 Jun;88(12):6896-905 7463489 - J Mol Evol. 1980 Dec;16(2):111-20 23593376 - PLoS One. 2013;8(4):e61009 2991595 - J Virol. 1985 Sep;55(3):768-77 3009890 - J Virol. 1986 Jun;58(3):825-34 6015694 - Science. 1967 Jan 27;155(3761):461-2 9847317 - J Virol. 1999 Jan;73(1):152-60 |
References_xml | – ident: e_1_3_3_62_2 doi: 10.1016/S1672-0229(07)60007-2 – ident: e_1_3_3_52_2 doi: 10.1128/jvi.58.3.825-834.1986 – volume: 3 start-page: 418 year: 1986 ident: e_1_3_3_61_2 article-title: Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions publication-title: Mol Biol Evol – ident: e_1_3_3_3_2 doi: 10.1038/35057062 – ident: e_1_3_3_42_2 doi: 10.1128/JVI.01267-13 – ident: e_1_3_3_54_2 doi: 10.1002/9780470649367 – ident: e_1_3_3_18_2 doi: 10.1128/jvi.69.8.4675-4682.1995 – ident: e_1_3_3_35_2 doi: 10.1128/JVI.75.22.11244-11248.2001 – ident: e_1_3_3_2_2 doi: 10.1128/JVI.72.7.5955-5966.1998 – ident: e_1_3_3_28_2 doi: 10.1016/j.placenta.2012.05.005 – ident: e_1_3_3_40_2 doi: 10.1371/journal.pone.0061009 – ident: e_1_3_3_49_2 doi: 10.1016/S0378-1119(97)00384-3 – ident: e_1_3_3_15_2 doi: 10.1073/pnas.071432398 – ident: e_1_3_3_59_2 doi: 10.1093/molbev/mst197 – ident: e_1_3_3_29_2 doi: 10.1186/1742-4690-2-52 – ident: e_1_3_3_17_2 doi: 10.1128/jvi.61.9.2852-2856.1987 – ident: e_1_3_3_24_2 doi: 10.1038/382826a0 – start-page: 393 volume-title: Proceedings of the Third International Feline Leukemia Virus Meeting. Elsevier/North-Holland Publishing Co. year: 1980 ident: e_1_3_3_51_2 – ident: e_1_3_3_58_2 doi: 10.1007/BF01731581 – ident: e_1_3_3_16_2 doi: 10.1155/2012/682850 – ident: e_1_3_3_12_2 doi: 10.1128/JVI.00288-14 – ident: e_1_3_3_19_2 doi: 10.1128/jvi.66.2.865-874.1992 – ident: e_1_3_3_68_2 doi: 10.1016/j.ympev.2009.02.023 – ident: e_1_3_3_31_2 doi: 10.1016/0042-6822(83)90324-0 – ident: e_1_3_3_41_2 doi: 10.1128/JVI.00280-12 – ident: e_1_3_3_5_2 doi: 10.1093/molbev/msi088 – ident: e_1_3_3_20_2 doi: 10.1016/S0021-9258(18)53779-0 – ident: e_1_3_3_63_2 doi: 10.1016/j.virol.2010.06.004 – ident: e_1_3_3_65_2 doi: 10.1128/JVI.73.7.5621-5629.1999 – ident: e_1_3_3_21_2 doi: 10.1038/360358a0 – ident: e_1_3_3_22_2 doi: 10.1038/35001608 – ident: e_1_3_3_39_2 doi: 10.1016/j.vetimm.2011.06.003 – ident: e_1_3_3_47_2 doi: 10.1182/blood.V95.3.1093.003k01_1093_1099 – ident: e_1_3_3_71_2 doi: 10.1126/science.287.5459.1828 – ident: e_1_3_3_45_2 doi: 10.1128/JVI.75.22.10563-10572.2001 – ident: e_1_3_3_46_2 doi: 10.1128/JVI.73.8.6500-6505.1999 – ident: e_1_3_3_6_2 doi: 10.1073/pnas.0307800101 – ident: e_1_3_3_60_2 doi: 10.1128/JVI.73.1.152-160.1999 – ident: e_1_3_3_70_2 doi: 10.1016/j.micinf.2007.09.012 – ident: e_1_3_3_36_2 doi: 10.1093/nar/gkr562 – ident: e_1_3_3_9_2 doi: 10.1128/jvi.63.10.4234-4241.1989 – ident: e_1_3_3_10_2 doi: 10.1073/pnas.0704313104 – ident: e_1_3_3_8_2 doi: 10.1016/0168-1702(88)90035-4 – ident: e_1_3_3_67_2 doi: 10.1016/j.virol.2010.06.017 – ident: e_1_3_3_43_2 doi: 10.1128/JVI.80.7.3378-3385.2006 – ident: e_1_3_3_30_2 doi: 10.1128/JVI.03653-14 – ident: e_1_3_3_38_2 doi: 10.1038/onc.2013.366 – ident: e_1_3_3_37_2 doi: 10.1007/s00018-006-6201-9 – ident: e_1_3_3_69_2 doi: 10.1128/JVI.79.24.15573-15577.2005 – ident: e_1_3_3_7_2 doi: 10.1093/oxfordjournals.molbev.a004108 – volume: 8 start-page: 275 year: 1992 ident: e_1_3_3_57_2 article-title: The rapid generation of mutation data matrices from protein sequences publication-title: Comput Appl Biosci – ident: e_1_3_3_33_2 doi: 10.1128/jvi.63.12.5405-5412.1989 – ident: e_1_3_3_11_2 doi: 10.1371/journal.ppat.0030010 – ident: e_1_3_3_27_2 doi: 10.1128/JVI.79.15.9677-9684.2005 – ident: e_1_3_3_66_2 doi: 10.1128/jvi.66.8.4966-4971.1992 – ident: e_1_3_3_34_2 doi: 10.1128/jvi.64.3.1033-1043.1990 – ident: e_1_3_3_50_2 doi: 10.1128/jvi.4.5.549-553.1969 – ident: e_1_3_3_72_2 doi: 10.1128/JVI.73.6.5034-5042.1999 – ident: e_1_3_3_23_2 doi: 10.1126/science.155.3761.461 – ident: e_1_3_3_26_2 doi: 10.1128/JVI.76.16.8218-8224.2002 – ident: e_1_3_3_4_2 doi: 10.1038/nature01262 – ident: e_1_3_3_25_2 doi: 10.1128/jvi.71.7.5652-5657.1997 – ident: e_1_3_3_13_2 doi: 10.3390/v7010001 – ident: e_1_3_3_14_2 doi: 10.1126/science.277.5332.1662 – ident: e_1_3_3_53_2 doi: 10.1128/jvi.49.2.629-632.1984 – ident: e_1_3_3_56_2 doi: 10.1093/nar/gkh340 – ident: e_1_3_3_44_2 doi: 10.1128/jvi.66.2.1219-1222.1992 – ident: e_1_3_3_55_2 doi: 10.1128/jvi.45.1.1-9.1983 – ident: e_1_3_3_32_2 doi: 10.1128/jvi.55.3.768-777.1985 – ident: e_1_3_3_48_2 doi: 10.1099/0022-1317-36-1-59 – ident: e_1_3_3_64_2 doi: 10.1128/jvi.71.9.7012-7019.1997 – reference: 15659556 - Mol Biol Evol. 2005 Apr;22(4):814-7 – reference: 10710311 - Science. 2000 Mar 10;287(5459):1828-30 – reference: 11237011 - Nature. 2001 Feb 15;409(6822):860-921 – reference: 10233966 - J Virol. 1999 Jun;73(6):5034-42 – reference: 16107223 - Retrovirology. 2005;2:52 – reference: 886304 - J Gen Virol. 1977 Jul;36(1):59-74 – reference: 9358069 - Gene. 1997 Oct 15;199(1-2):293-301 – reference: 9261431 - J Virol. 1997 Sep;71(9):7012-9 – reference: 22695103 - Placenta. 2012 Sep;33(9):663-71 – reference: 20591459 - Virology. 2010 Sep 15;405(1):214-24 – reference: 8752279 - Nature. 1996 Aug 29;382(6594):826-9 – reference: 9621058 - J Virol. 1998 Jul;72(7):5955-66 – reference: 9847317 - J Virol. 1999 Jan;73(1):152-60 – reference: 22811910 - Mol Biol Int. 2012;2012:682850 – reference: 9188643 - J Virol. 1997 Jul;71(7):5652-7 – reference: 6015694 - Science. 1967 Jan 27;155(3761):461-2 – reference: 24132122 - Mol Biol Evol. 2013 Dec;30(12):2725-9 – reference: 11919294 - Mol Biol Evol. 2002 Apr;19(4):526-33 – reference: 22674983 - J Virol. 2012 Aug;86(16):8634-44 – reference: 23966402 - J Virol. 2013 Nov;87(22):12029-40 – reference: 16871371 - Cell Mol Life Sci. 2006 Aug;63(16):1906-11 – reference: 15044706 - Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4894-9 – reference: 1360148 - Nature. 1992 Nov 26;360(6402):358-61 – reference: 3039173 - J Virol. 1987 Sep;61(9):2852-6 – reference: 24013223 - Oncogene. 2014 Jul 24;33(30):3947-58 – reference: 1629961 - J Virol. 1992 Aug;66(8):4966-71 – reference: 10364311 - J Virol. 1999 Jul;73(7):5621-9 – reference: 7609032 - J Virol. 1995 Aug;69(8):4675-82 – reference: 11602698 - J Virol. 2001 Nov;75(22):10563-72 – reference: 25549291 - Viruses. 2015 Jan;7(1):1-26 – reference: 2555565 - J Virol. 1989 Dec;63(12):5405-12 – reference: 6296423 - J Virol. 1983 Jan;45(1):1-9 – reference: 20655565 - Virology. 2010 Sep 30;405(2):548-55 – reference: 3009890 - J Virol. 1986 Jun;58(3):825-34 – reference: 12466850 - Nature. 2002 Dec 5;420(6915):520-62 – reference: 1309898 - J Virol. 1992 Feb;66(2):1219-22 – reference: 21771862 - Nucleic Acids Res. 2011 Nov 1;39(20):8728-39 – reference: 2778873 - J Virol. 1989 Oct;63(10):4234-41 – reference: 2833049 - Virus Res. 1988 Feb;9(2-3):263-83 – reference: 1633570 - Comput Appl Biosci. 1992 Jun;8(3):275-82 – reference: 19298858 - Mol Phylogenet Evol. 2009 Jun;51(3):465-71 – reference: 21807418 - Vet Immunol Immunopathol. 2011 Oct 15;143(3-4):190-201 – reference: 10648427 - Blood. 2000 Feb 1;95(3):1093-9 – reference: 1370559 - J Virol. 1992 Feb;66(2):865-74 – reference: 16014929 - J Virol. 2005 Aug;79(15):9677-84 – reference: 18023391 - Microbes Infect. 2007 Nov-Dec;9(14-15):1590-6 – reference: 10400745 - J Virol. 1999 Aug;73(8):6500-5 – reference: 2991595 - J Virol. 1985 Sep;55(3):768-77 – reference: 11274436 - Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4113-8 – reference: 16306628 - J Virol. 2005 Dec;79(24):15573-7 – reference: 25653437 - J Virol. 2015 Apr;89(8):4047-50 – reference: 17257061 - PLoS Pathog. 2007 Jan;3(1):e10 – reference: 12134027 - J Virol. 2002 Aug;76(16):8218-24 – reference: 10693809 - Nature. 2000 Feb 17;403(6771):785-9 – reference: 17959780 - Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17506-11 – reference: 7463489 - J Mol Evol. 1980 Dec;16(2):111-20 – reference: 9287219 - Science. 1997 Sep 12;277(5332):1662-6 – reference: 4311790 - J Virol. 1969 Nov;4(5):549-53 – reference: 6192586 - Virology. 1983 Jul 15;128(1):127-39 – reference: 8381404 - J Biol Chem. 1993 Feb 5;268(4):2329-36 – reference: 24696495 - J Virol. 2014 Jun;88(12):6896-905 – reference: 3444411 - Mol Biol Evol. 1986 Sep;3(5):418-26 – reference: 16537605 - J Virol. 2006 Apr;80(7):3378-85 – reference: 6319767 - J Virol. 1984 Feb;49(2):629-32 – reference: 23593376 - PLoS One. 2013;8(4):e61009 – reference: 2304138 - J Virol. 1990 Mar;64(3):1033-43 – reference: 17531802 - Genomics Proteomics Bioinformatics. 2006 Nov;4(4):259-63 – reference: 15034147 - Nucleic Acids Res. 2004;32(5):1792-7 – reference: 11602766 - J Virol. 2001 Nov;75(22):11244-8 |
SSID | ssj0014464 |
Score | 2.2621748 |
Snippet | Endogenous retroviruses (ERVs) are remnants of ancestral retroviral infections of germ cells. Retroviral endogenization is an adaptation process for the host... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1470 |
SubjectTerms | Animals Cats Endogenous Retroviruses - immunology Feline leukemia virus Gene Expression Profiling Genetic Diversity and Evolution Host-Pathogen Interactions Leukemia Virus, Feline - immunology Molecular Sequence Data Mutant Proteins - genetics Mutant Proteins - metabolism Retrovirus Reverse Genetics Sequence Analysis, DNA Viral Envelope Proteins - genetics Viral Envelope Proteins - metabolism Virus Assembly Virus Replication |
Title | Ancestral Mutations Acquired in Refrex-1, a Restriction Factor against Feline Retroviruses, during its Cooption and Domestication |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26581999 https://www.proquest.com/docview/1760900510 https://www.proquest.com/docview/1768570070 https://pubmed.ncbi.nlm.nih.gov/PMC4719600 |
Volume | 90 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFB6FIiQuiJ2waZDglLrY4_F2jCqiNhU9oBT1Zs2WEkHtKrEF7Q1-Oe_N2I5DKAIuVuSZxJK_L2--efMWQl5HTCUqTjOPJ5p5XHPtCW2YJ7NYmjnPQmFsgOxxfHDCp6fR6WDwoxe1VFdyT139Nq_kf1CFe4ArZsn-A7Ldj8IN-Az4whUQhutfYTzGGGh0VYze11UT0zZWGNtrsKQSvLv50nzzAhuiiZ56LMdvAZ_YNjsjcSYWoA9HE2PV5gdToYdhWa-c8WhyGPFsYb8snXGxocvlORbnUGtUt-Ut5s_1PfaHlTvjAfqYxdp_Kq14nYnP9WW3QByJr2IlXD_tKQjsbuAYHWZnzciRuKrLvtMi6OKccc1xhhbrmKJa61ti1zi0YVzYM6sBd91Ftu09wxyG6cfDPcyJ555LDe1Bf3FusWcgtLDgwnrV62IR26Eb5CaDrUbYenyakyjYLvM2YYKlb_uPwkLSzZc3Vc3WVuXXiNuehJndJXcacOjYEekeGZjiPrnlupFePiDfOzrRjk60pRNdFLSl0y4VtEcm6shEGzJRRybaJ9MudVSiQCXaUokClegGlR6Sk8m72f6B13To8BRPw8qb-0ZLUOBzMONR6msRcqPChInI16A9TWQypWCS0GGqQ4PFJo1gWcBiiY4IFj4iO0VZmCeERiYIpOBSSBlyGcTZPFBMZ1z7sGXIYjMko_YN56opX49dVL7kdhvL0hygyS00eRANyZtu9oUr23LNvFctWDnYVTwsE4Up61UeJLGf2SXrj3Nsf4gE5jx2AHdPa5kxJMkG9N0ErOu-OVIsPtn67qAXM9iHPL32N5-R2-s_1XOyUy1r8wK0cSVfWvL-BJFVvzk |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ancestral+Mutations+Acquired+in+Refrex-1%2C+a+Restriction+Factor+against+Feline+Retroviruses%2C+during+its+Cooption+and+Domestication&rft.jtitle=Journal+of+virology&rft.au=Ito%2C+Jumpei&rft.au=Baba%2C+Takuya&rft.au=Kawasaki%2C+Junna&rft.au=Nishigaki%2C+Kazuo&rft.date=2016-02-01&rft.eissn=1098-5514&rft.volume=90&rft.issue=3&rft.spage=1470&rft_id=info:doi/10.1128%2FJVI.01904-15&rft_id=info%3Apmid%2F26581999&rft.externalDocID=26581999 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |